Healthy person
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Individuals aged 20 to 65 years who do not meet the exclusion criteria. 2.Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily.
Exclusion criteria
Exclusion criteria: 1.Individuals with a history of serious diseases related to the brain, nervous system, cardiovascular system, or other severe conditions, or those currently undergoing treatment, including those taking prescribed medication. 2.Individuals with a history of seizures (such as loss of consciousness, coma, convulsions, etc.). 3.Individuals with hearing or vision impairments that make it difficult to complete the essential evaluation items of this study. 4.Individuals who are currently pregnant or breastfeeding. 5.Individuals currently participating in another clinical trial or who have participated in another interventional clinical trial within one month prior to obtaining consent. 6. Individuals deemed unsuitable by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Autonomic nerve function | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive task score Fatigue VAS score Concentrations of salivary cortisol and amylase | — |
Countries
Japan
Contacts
Osaka Metropolitan University Center for Health Science Innovation